These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23376859)

  • 21. Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
    Treglia G; Cocciolillo F; Di Nardo F; Poscia A; de Waure C; Giordano A; Rufini V
    Acad Radiol; 2012 Oct; 19(10):1290-9. PubMed ID: 22819076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluorine-18 L-3,4-dihydroxyphenylalanine positron emission tomography: improving surgery and outcome in focal hyperinsulinism. Commentary to Mohnike et al.: Proposal for a standardized protocol for F-DOPA-PET (PET/CT) in congenital hyperinsulinism (Horm Res 2006;66:40-42).
    Shield JP
    Horm Res; 2006; 66(1):43-4. PubMed ID: 16710095
    [No Abstract]   [Full Text] [Related]  

  • 24. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
    Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by
    Zhang MY; Ni JW; Ge JJ; Guan YH; Pei Z; Sun CJ; Wu J; Xu ZR; Yang L; Luo FH; Cheng RQ
    Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):853-858. PubMed ID: 34587682
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
    Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism.
    States LJ; Saade-Lemus S; De Leon DD
    PET Clin; 2020 Jul; 15(3):349-359. PubMed ID: 32498990
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Boss M; Rottenburger C; Brenner W; Blankenstein O; Prasad V; Prasad S; Coppi P; Kühnen P; Buitinga M; Nuutila P; Otonkoski T; Hussain K; Brom M; Eek A; Bomanji J; Shah P; Gotthardt M
    J Nucl Med; 2022 Feb; 63(2):310-315. PubMed ID: 34215672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
    Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
    Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    States LJ; Davis JC; Hamel SM; Becker SA; Zhuang H
    J Nucl Med; 2021 Jul; 62(Suppl 2):51S-56S. PubMed ID: 34230074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.
    Luster M; Karges W; Zeich K; Pauls S; Verburg FA; Dralle H; Glatting G; Buck AK; Solbach C; Neumaier B; Reske SN; Mottaghy FM
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):484-93. PubMed ID: 19862519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. F-18 DOPA PET/CT in pediatric patients with hyperinsulinemic hypoglycemia: A correlation with genetic analysis.
    Sagar S; Arora G; Damle N; Sharma R; Jain V; Jana M; Tripathi M; Bal C; Goel P
    Nucl Med Commun; 2022 Apr; 43(4):451-457. PubMed ID: 35045547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
    Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G
    Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
    Koopmans KP; de Vries EG; Kema IP; Elsinga PH; Neels OC; Sluiter WJ; van der Horst-Schrivers AN; Jager PL
    Lancet Oncol; 2006 Sep; 7(9):728-34. PubMed ID: 16945767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
    Morana G; Puntoni M; Garrè ML; Massollo M; Lopci E; Naseri M; Severino M; Tortora D; Rossi A; Piccardo A
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1664-72. PubMed ID: 26911489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
    Marzola MC; Pelizzo MR; Ferdeghini M; Toniato A; Massaro A; Ambrosini V; Fanti S; Gross MD; Al-Nahhas A; Rubello D
    Eur J Surg Oncol; 2010 Apr; 36(4):414-21. PubMed ID: 20100647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
    Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form: Not a focal lesion in the pancreas reported by ¹⁸F-DOPA-PET/CT scan.
    Zhang W; Liu L; Wen Z; Cheng J; Li C; Li X; Niu H; Wang F; Sheng H; Liu H
    Gene; 2015 Nov; 572(2):222-6. PubMed ID: 26162674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.